KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (Diluted Average) (2017 - 2026)

Elanco Animal Health's Shares Outstanding (Diluted Average) history spans 9 years, with the latest figure at $496.4 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed 0.18% to $496.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $496.4 million, a 0.18% change, with the full-year FY2025 number at $496.4 million, changed 0.18% from a year prior.
  • Shares Outstanding (Diluted Average) hit $496.4 million in Q4 2025 for Elanco Animal Health, down from $501.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for ELAN hit a ceiling of $501.2 million in Q3 2025 and a floor of $486.7 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $492.8 million across 5 years, with a median of $492.4 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 20.5% in 2021 and later fell 0.18% in 2025.
  • Tracing ELAN's Shares Outstanding (Diluted Average) over 5 years: stood at $487.2 million in 2021, then rose by 0.23% to $488.3 million in 2022, then increased by 0.82% to $492.3 million in 2023, then rose by 1.02% to $497.3 million in 2024, then fell by 0.18% to $496.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ELAN at $496.4 million in Q4 2025, $501.2 million in Q3 2025, and $499.6 million in Q2 2025.